# Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy

> **NCT02716376** · NA · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Otitis Media With Effusion
- Chronic Otitis Media
- Hearing Loss

## Interventions

- **DEVICE:** Otovent®

## Key facts

- **NCT ID:** NCT02716376
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716376, "Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02716376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*